Category Archives: Education

Motivations in Liking What You Do

CPSA Everyday Conversation

Christophe Stove, Ghent University

“We don’t want everyone to come stand in line. Just do it yourself at home.” – Christophe Stove, Ghent University

Christophe Stove talks about training the next generation of researchers that will drive microsampling and improving patient care.  He has never felt like he is doing work, enjoys what he does, and gets to work on his hobby – feeling lucky that he has great students and collaborators.  His lab designs new workflows with microsampling that can often be translated to hospitals or the clinic.  Christophe has 20 years of experience in microsampling and can see increased adoption during the COVID-19 crisis.  He asks the question:  Why would you want people to come to an area to meet, if we can get the same sample at home at a micro level?  Especially those that are at high risk.  Acknowledging that not every condition can be tested in this way, but why not simply convert if we can?

The Patient at the Center: Ways to Make Patient Lives Better

Program Chair – 23rd Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)

Melanie Anderson, Merck

“What I love about CPSA is that it continues to ask the questions, what are we trying to do? And where is it that we are trying to go?”- Melanie Anderson, Merck

“Why are we taking 6 mL when we can take 100 µL?” – Melanie Anderson, Merck

With the pandemic, the design and execution of clinical trials has become more challenging.  Melanie asks the questions – “What are the ways that we can make a patient’s life better?”,   “What would be a better treatment?”  and “What can we do differently?”  Healthcare has fundamentally changed in the face of the pandemic, creating new challenges and opportunities for patients in clinical trials and their treatments.   Melanie puts forth a discussion on engaging patients to understand their needs – while building capabilities like telemedicine and at home microsampling.  We can work together to help change parts of a larger healthcare system, ultimately serving to improve patient care.

Considerations on Metabolomics and Integrative Omics – COVID-19 Response and Post Recovry Diseases

7th Annual Brasilian Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA BRASIL 2020)

Roundtable Session Coordinator – CPSA Brazil 2020
Regina Oliveira, Ph.D. from Universidade Federal de São Carlos

“My passion is to know that I can make a difference.”

“[Make the general public] feel more comfortable knowing that it will pass, and that science will help them find the solution, to take away from health problem”

“Need to think about the disease (COVID-19) after recovery.”

In a response to a pandemic such as COVID-19, Regina looks to not only collect relevant data from patient samples – she also educates her family, friends, and community that we will get through this crisis together. Along with education with generating accurate knowledge, her lab (among many projects) works on diseases related to COVID-19 that appear months to years after the infection and recovery. The knowledge is created through clinical research with metabolomics – a technology that has been on the front line for COVID-19 patients that present other diseases post recovery. Although complex in nature, Regina creates understandable biological knowledge that is helping patients – and can be shared with the population as a whole.

Roundtable Session – Lead by Regina Oliveira, Ph.D

Gustavo Simões, CEO Nanox, São Carlos, São Paulo, Brazil

Markus Schreyer, CEO & Founder, Ganeshalab

Valdemir Carvalho, Ph,D, Senior Scientific Consultant at Fleury Group, São Paulo, Brazil

Roundtable Contributors
Gustavo Mendes Lima Santos
Carlos Kiffer, MD, Ph.D.
Marc Chalom